Trial intelligence / Profile preview

Multi-Intervention Trial to Inhibit Precancerous Gastric Lesions in Linqu, China

NCT00339768Phase 3Completed

Sponsor
National Cancer Institute
Start
Jul 1995
Primary completion
Jun 1996
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 3 trial of amoxicillin, omeprazole, alpha-tocopherol, ascorbic acid, selenium in precancerous gastric lesions, sponsored by National Cancer Institute. Started Jul 1995; status: completed.

02

Drugs

amoxicillinomeprazolealpha-tocopherolascorbic acidselenium
03

Conditions

precancerous gastric lesions

Beyond the preview

Go deeper on NCT00339768.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00339768.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call